中華人民共和国の薬局における薬剤師の法的責任:医薬品の品質管理
書誌事項
- タイトル別名
-
- Pharmacists’ Legal Responsibilities in Pharmacies within the People’s Republic of China: The Quality Control of Medicines
この論文をさがす
抄録
<p>China’s pharmaceutical market, the second largest in the world, has recently attracted the attention of many countries. However, Chinese pharmacists’ role in pharmacies and their legal responsibilities in China are not well known in Japan. Clarifying Chinese pharmacists’ legal obligations and identifying their specific roles may contribute to improvements in pharmacy operations in Japan. To investigate the Chinese legal system as it pertains to pharmacists in China, we used China’s official government website. In 2019, there were 516,003 pharmacists in China. As of 2020, the Chinese Pharmacist Act is still in the preparatory stage; however, the Administrative Regulation, which describes the system for licensing pharmacists, has been established. Article 1 of the Administrative Regulation states that Chinese pharmacists are responsible for the quality control of medications, as well as medication consultations. Another regulation, Good Supply Practice, specifies that the lot numbers of medications should be provided to patients at the time of dispensing. We believe that this is particularly beneficial to pharmaceutical traceability. Since 2017, the circulation of counterfeit HARVONI® combination tablets has been a problem in Japan. To secure and improve the quality of medications in Japan, we believe that it is important for pharmacists to understand that they are “responsible for the quality of the medicine” and to promote discussions on pharmacy quality control tasks.</p>
収録刊行物
-
- 社会薬学
-
社会薬学 39 (2), 79-86, 2020-12-10
日本社会薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390849931317977984
-
- NII論文ID
- 130007964161
-
- ISSN
- 21882754
- 09110585
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可